Erste Asset Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,300
| Closed | -$56.3K | – | 857 |
|
|
2024
Q3 | $56.3K | Hold |
11,300
| – | – | ﹤0.01% | 508 |
|
|
2024
Q2 | $53.8K | Hold |
11,300
| – | – | ﹤0.01% | 507 |
|
|
2024
Q1 | $149K | Hold |
11,300
| – | – | ﹤0.01% | 480 |
|
|
2023
Q4 | $169K | Hold |
11,300
| – | – | ﹤0.01% | 487 |
|
|
2023
Q3 | $146K | Hold |
11,300
| – | – | ﹤0.01% | 492 |
|
|
2023
Q2 | $212K | Hold |
11,300
| – | – | ﹤0.01% | 488 |
|
|
2023
Q1 | $162K | Hold |
11,300
| – | – | ﹤0.01% | 507 |
|
|
2022
Q4 | $213K | Hold |
11,300
| – | – | ﹤0.01% | 491 |
|
|
2022
Q3 | $386K | Hold |
11,300
| – | – | 0.01% | 447 |
|
|
2022
Q2 | $175K | Hold |
11,300
| – | – | ﹤0.01% | 518 |
|
|
2022
Q1 | $274K | Buy |
+11,300
| New | +$274K | 0.01% | 489 |
|